Menu
Washingtoner
  • Home
  • Health
  • Artificial Intelligence
  • Technology
  • Entertainment
  • Real Estate
  • Software
  • Concealed Carry
  • Information Technology
Washingtoner

Study Finds Lotus Vaping Technologies' Flavored E-Liquids Reduce Smokers' Cigarettes Per Day at Significantly Higher Rate Than Tobacco Flavor
Washingtoner/10239600

Trending...
  • Tacoma: 'Capital Ready: Preparing Businesses for Growth in Public Contracting' Workshop on October 27
  • Spokane: SPD Seeks Assistance in Locating Vehicle Associated in Hit and Run
  • Final Week to Register for Free Spokane Community Conference
A rigorous three-month longitudinal cohort study of several of flavored bottled e-liquids demonstrated that those flavors were significantly more effective at reducing cigarettes smoked per day than tobacco-flavored e-liquids.

BOISE, Idaho - Washingtoner -- Lotus Vaping Technologies, LLC, a Boise, Idaho-based manufacturer of bottled e-liquids for use in electronic nicotine delivery systems ("ENDS") or e-cigarettes, announced today that a rigorous three-month longitudinal cohort study of several of its FreenomsTM branded flavored bottled e-liquids demonstrated that those flavors were significantly more effective at reducing cigarettes smoked per day than tobacco-flavored e-liquids.

The three-month study conducted from March 2023 to August 2023 involved 451 randomly assigned participants who were cigarette smokers, 221 of which were assigned to a control group that used only tobacco-flavored e-liquid, and 230 of which were assigned to a group that could use any of five different non-tobacco flavored bottled e-liquids, including Lotus's proprietary BluenomenomTM, StranomenonTM, X2 Cactus Jackfruit, and White Peach Raspberry flavors.

More on Washingtoner
  • Soft & Sweet Unveils New Studio Location and Website for All-Natural Sugaring in Las Vegas
  • Beyond Popularity Rankings, The World's No.1 Superstar® Wins Best Pop Music Video for "Under Your Spell"
  • Spokane: SPD Seeks the Public's Assistance in Locating 94-year-old man
  • Simpalm Staffing Launches Tax Preparer Staffing for U.S. CPA Firms
  • ASSIST Software Wins Volkswagen Challenge for Automated Quality Inspection

At the end of three months, the average number of cigarettes smoked per day ("CPD") by the tobacco-flavored control group was reduced from 12.51 to 9.54, for a 23.72% reduction, while for the flavored e-liquid group, the average CPD was reduced from 11.70 to 6.88, for a 41.25% reduction.  The reduction in cigarettes smoked per day was thus 73.9% greater for the flavored group than the tobacco-flavored group. The study results also demonstrated statistically significant differences between several of Lotus's flavored e-liquids when compared head-to-head against tobacco-flavored e-liquids with respect to CPD reduction.

Additionally, a full 14.3% of study participants in the flavored group had quit smoking cigarettes altogether by the end of the third month—a rate that is substantially higher than that typically reported for FDA-approved nicotine replacement therapy products (9.0%).

Lotus's Director of Sales, Mike Larsen stated, "We are very excited about these study results. This study demonstrates what users of our products have known anecdotally for a long time—flavored e-liquids are more effective than tobacco flavor at promoting cigarette smoking reduction and cessation. The FDA has been asking for this data—we hope it will now take it into consideration when reviewing our premarket tobacco product applications and grant our flavored products the marketing authorizations that they deserve."

More on Washingtoner
  • National Literacy and Workforce Readiness Crisis Sparks New Program Launching in Birmingham
  • New England Consulting Partners Celebrates 25 Years of Turnaround Management Solutions
  • RAS AP Consulting Releases Educational Resource to Help Organizations Prepare for IRS FIRE-to-IRIS Transition
  • Roots, Rhythm & Joy Invites Neighbors to Find Community Through Music
  • Tacoma: Homicide Investigation – 1100 Commerce Street

About Lotus Vaping Technologies, LLC – Creator of NomenonsTM E-Liquids

Established in 2013, Lotus is a leading manufacturer and wholesaler of premium e-liquids in the United States providing a diverse range of vapor products for sale to adult consumers that satisfy a wide variety of consumer preferences and serve as alternatives to combustible cigarettes. Lotus is committed to responsible manufacturing processes and utilizes only the highest standards in its e-liquid production.

Media Contact
Mike Larsen
mike@lotusecigs.com


Source: Lotus Vaping Technologies, LLC
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Breathwork Certification in Seattle, Washington State: First Pacific Northwest Date Set
  • Author Robert A. Robinson Introduces Anarchy at the AYP:
  • Renew Integrative Health Publishes Updated Peptide Therapy Guide to Help Patients Understand Their Options
  • AI Agents Are Getting Their Own Computers. HRTech Leading in Vertical Harness Development
  • UK Financial Ltd Announces Two-for-One Upgrade of Maya 3 to Maya 3G Token Using Chainlink Cross-Chain Technology
  • Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Spokane City Council Passes Community Safety Sales Tax
  • AutoProIT Achieves Cyber Essentials Certification, Reinforcing Its Commitment to Secure Digital Transformation
  • DayPass llega a ChatGPT y Claude
  • DayPass launches in ChatGPT and Claude
  • Renkeer Water Quality Sensors Support Efficient Operation of AI Liquid Cooling Systems
  • Victor Archibong Expands ItsArchiDuh Creator Brand
  • ClearSight Therapeutics Receives U.S. Patent Notice of Allowance
  • Revinate launches hospitality's first data activation platform
  • HLN Consulting Names Lilly Kan as Its First Chief Executive Officer
  • BitTitan Accelerates Large-Scale Document Migrations with MigrationWiz
  • Clearnetworx Deploys netElastic vBNG, CGNAT And netVision To Power Fiber Expansion Across Colorado's Western Slope
  • Spokane: SPD Seeks Assistance in Locating Vehicle Associated in Hit and Run
  • Tacoma: 'Capital Ready: Preparing Businesses for Growth in Public Contracting' Workshop on October 27
  • Six Tacoma Census Tracts Nominated by Governor Bob Ferguson as Federal 'Opportunity Zones'
_catLbl0 _catLbl1

Popular on Washingtoner

  • Spokane: Police Arrest Registered Sex Offender for Child Sexual Abuse Material - 322
  • ResC4EU Final Event at KOMPOZYT-EXPO 2026 – Building Resilient European Supply Chains - 207
  • CinderLabs Launches AI Agent Marketplace: Nine Pre-Built Agents for Regulated Industries - 162
  • Spokane: Convicted Felon Arrested in Vancouver After Eluding SPD Officers - 149
  • City of Spokane to Install First 'Emergency Streets' Lane Closure After Weekend Fatal Crash - 148
  • City of Tacoma Invites Community Members to Share Their Experience Crossing I-5 - 139
  • Spokane: City and Permittable Partner to Support Rebuilding After Wildfires - 120
  • Inglewood Associates and Gordon Brothers Provide Update on Sale Process for 925 Euclid Avenue in Cleveland - 106
  • JEGS Launches Transformed Digital Commerce Platform Powered by PhaseZero - 102
  • Tacoma: In-Person Workshop on October 22 for Local Businesses on the City’s Revolving Loan Fund Process

Similar on Washingtoner

  • Hospital Direct Medical Equipment Company Seeing Growth in Used Refurbished Medical Equipment Sales
  • Soft & Sweet Unveils New Studio Location and Website for All-Natural Sugaring in Las Vegas
  • Good Organics Now at Pop Up Grocer NYC With October 30 Sampling Event
  • Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP
  • Breathwork Certification in Seattle, Washington State: First Pacific Northwest Date Set
  • Renew Integrative Health Publishes Updated Peptide Therapy Guide to Help Patients Understand Their Options
  • Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • ClearSight Therapeutics Receives U.S. Patent Notice of Allowance
  • HLN Consulting Names Lilly Kan as Its First Chief Executive Officer
  • Meta Partnership Expanding as Omni One Orders Surge 3X -New Consumer Bundles, Defense Opportunities & AI Robotics: Virtuix Holdings: N A S D A Q: VTIX
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute